{"entity":{"type":"insider","cik":"0001365618","url":"/insider/0001365618","json_url":"/insider/0001365618.json","name":"Hove Anders D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":22,"first":"2006-10-25","last":"2025-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Hove Anders D","source":"filing","n_filings":22,"first_seen":"2006-10-25","last_seen":"2025-05-19"}],"transactions":[{"id":4341428,"accession":"0000950170-25-074459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-074459","line_url":"/filing/0000950170-25-074459","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":null,"owner_name":"ACORN BIOVENTURES, L.P.; ACORN CAPITAL ADVISORS GP, LLC; Hove Anders D","owner_display_name":"ACORN BIOVENTURES, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400000.0,"shares_display":"1,400,000","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":2590000.0,"total_display":"2,590,000.00","total_whole":"2,590,000","shares_owned_after":1129730.0,"shares_owned_after_display":"1,129,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider","n_lines":2},{"id":6747651,"accession":"0001104659-18-031864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-031864","line_url":"/filing/0001104659-18-031864#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Inspire Medical Systems, Inc.","issuer_ticker":"INSP","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":null,"owner_name":"Amzak Health Investors, LLC; Kazma Michael D; Hove Anders D","owner_display_name":"Amzak Health Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":1497043.0,"shares_owned_after_display":"1,497,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider"},{"id":2806358,"accession":"0001365618-16-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001365618-16-000009","line_url":"/filing/0001365618-16-000009","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":353881.0,"shares_display":"353,881","price_per_share":99.58631941245785,"price_display":"99.59","price_state":"stated","total_value":35241706.3,"total_display":"35,241,706.30","total_whole":"35,241,706","shares_owned_after":72385.0,"shares_owned_after_display":"72,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider","n_lines":3},{"id":2528965,"accession":"0001365618-16-000007","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001365618-16-000007","line_url":"/filing/0001365618-16-000007","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4268.0,"shares_display":"4,268","price_per_share":70.1765229615745,"price_display":"70.18","price_state":"stated","total_value":299513.4,"total_display":"299,513.40","total_whole":"299,513","shares_owned_after":96634.0,"shares_owned_after_display":"96,634","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-08","filed_date":"2016-04-11","scope":"insider","n_lines":2},{"id":2528957,"accession":"0001365618-16-000007","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001365618-16-000007","line_url":"/filing/0001365618-16-000007","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225033.0,"shares_display":"225,033","price_per_share":71.12037665586826,"price_display":"71.12","price_state":"stated","total_value":16004431.72,"total_display":"16,004,431.72","total_whole":"16,004,432","shares_owned_after":222775.0,"shares_owned_after_display":"222,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-11","scope":"insider","n_lines":6},{"id":8507689,"accession":"0001365618-15-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-15-000006","line_url":"/filing/0001365618-15-000006#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900000.0,"shares_display":"900,000","price_per_share":111.25,"price_display":"111.25","price_state":"stated","total_value":100125000.0,"total_display":"100,125,000.00","total_whole":"100,125,000","shares_owned_after":325535.0,"shares_owned_after_display":"325,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8730409,"accession":"0001365618-15-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-15-000005","line_url":"/filing/0001365618-15-000005#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":117.36,"price_display":"117.36","price_state":"stated","total_value":4694400.0,"total_display":"4,694,400.00","total_whole":"4,694,400","shares_owned_after":33886.0,"shares_owned_after_display":"33,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-15","scope":"insider"},{"id":8380278,"accession":"0001365618-15-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001365618-15-000004","line_url":"/filing/0001365618-15-000004#line-3","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100295.0,"shares_display":"100,295","price_per_share":103.6,"price_display":"103.60","price_state":"stated","total_value":10390562.0,"total_display":"10,390,562.00","total_whole":"10,390,562","shares_owned_after":1598517.0,"shares_owned_after_display":"1,598,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-11-12","scope":"insider"},{"id":8526620,"accession":"0001140361-15-037182","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-037182","line_url":"/filing/0001140361-15-037182#line-3","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4950000.0,"total_display":"4,950,000.00","total_whole":"4,950,000","shares_owned_after":2021917.0,"shares_owned_after_display":"2,021,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-06","filed_date":"2015-10-08","scope":"insider"},{"id":6465923,"accession":"0001365618-14-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-14-000004","line_url":"/filing/0001365618-14-000004#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":2725535.0,"shares_owned_after_display":"2,725,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-26","filed_date":"2014-09-30","scope":"insider"},{"id":6445220,"accession":"0001365618-14-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001365618-14-000003","line_url":"/filing/0001365618-14-000003#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738500.0,"shares_display":"738,500","price_per_share":24.87,"price_display":"24.87","price_state":"stated","total_value":18366495.0,"total_display":"18,366,495.00","total_whole":"18,366,495","shares_owned_after":2745535.0,"shares_owned_after_display":"2,745,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2014-09-22","scope":"insider"},{"id":6445216,"accession":"0001365618-14-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-14-000003","line_url":"/filing/0001365618-14-000003#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":24.87,"price_display":"24.87","price_state":"stated","total_value":37305.0,"total_display":"37,305.00","total_whole":"37,305","shares_owned_after":3484035.0,"shares_owned_after_display":"3,484,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-18","filed_date":"2014-09-22","scope":"insider"},{"id":6242057,"accession":"0001365618-14-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001365618-14-000002","line_url":"/filing/0001365618-14-000002#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":24.99,"price_display":"24.99","price_state":"stated","total_value":1874250.0,"total_display":"1,874,250.00","total_whole":"1,874,250","shares_owned_after":3485535.0,"shares_owned_after_display":"3,485,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-16","scope":"insider"},{"id":6242053,"accession":"0001365618-14-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-14-000002","line_url":"/filing/0001365618-14-000002#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":24.98,"price_display":"24.98","price_state":"stated","total_value":374700.0,"total_display":"374,700.00","total_whole":"374,700","shares_owned_after":3560535.0,"shares_owned_after_display":"3,560,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-16","scope":"insider"},{"id":6589360,"accession":"0001495384-14-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001495384-14-000004","line_url":"/filing/0001495384-14-000004#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":null,"owner_name":"VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; Venrock Associates VI, L.P.; Venrock Partners VI, L.P.; Venrock Management VI, LLC; Venrock Partners Management VI, LLC; Hove Anders D; Koh Bong Y; VHCP Co-Investment Holdings, LLC","owner_display_name":"VENROCK HEALTHCARE CAPITAL PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":6800000.0,"total_display":"6,800,000.00","total_whole":"6,800,000","shares_owned_after":2365471.0,"shares_owned_after_display":"2,365,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":5085358,"accession":"0001365618-13-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-13-000002","line_url":"/filing/0001365618-13-000002#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":2109000.0,"total_display":"2,109,000.00","total_whole":"2,109,000","shares_owned_after":3575535.0,"shares_owned_after_display":"3,575,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":2259254,"accession":"0001365618-12-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-12-000006","line_url":"/filing/0001365618-12-000006#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19273.0,"shares_display":"19,273","price_per_share":6.3019,"price_display":"6.30","price_state":"stated","total_value":121456.5187,"total_display":"121,456.52","total_whole":"121,457","shares_owned_after":3725535.0,"shares_owned_after_display":"3,725,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-20","filed_date":"2012-09-24","scope":"insider"},{"id":2226618,"accession":"0001365618-12-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-12-000005","line_url":"/filing/0001365618-12-000005#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":6.5087,"price_display":"6.51","price_state":"stated","total_value":227804.5,"total_display":"227,804.50","total_whole":"227,805","shares_owned_after":3744808.0,"shares_owned_after_display":"3,744,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-14","filed_date":"2012-09-18","scope":"insider"},{"id":3032694,"accession":"0001365618-12-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001365618-12-000004","line_url":"/filing/0001365618-12-000004#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.5553,"price_display":"6.56","price_state":"stated","total_value":98329.5,"total_display":"98,329.50","total_whole":"98,330","shares_owned_after":3779808.0,"shares_owned_after_display":"3,779,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-13","filed_date":"2012-09-13","scope":"insider"},{"id":3032691,"accession":"0001365618-12-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-12-000004","line_url":"/filing/0001365618-12-000004#line-1","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10177.0,"shares_display":"10,177","price_per_share":6.6427,"price_display":"6.64","price_state":"stated","total_value":67602.7579,"total_display":"67,602.76","total_whole":"67,603","shares_owned_after":3794808.0,"shares_owned_after_display":"3,794,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-11","filed_date":"2012-09-13","scope":"insider"},{"id":9106263,"accession":"0001458177-11-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001458177-11-000002","line_url":"/filing/0001458177-11-000002#line-1","is_derivative":false,"issuer_cik":"0001239242","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001239242","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings, LLC; Hove Anders D; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; ROBERTS BRYAN E","owner_display_name":"VHCP Co-Investment Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":4.9999,"price_display":"5.00","price_state":"stated","total_value":374992.5,"total_display":"374,992.50","total_whole":"374,993","shares_owned_after":5189934.0,"shares_owned_after_display":"5,189,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-02","filed_date":"2011-02-04","scope":"insider"},{"id":7437107,"accession":"0001365618-10-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001365618-10-000007","line_url":"/filing/0001365618-10-000007#line-5","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":2625535.0,"shares_owned_after_display":"2,625,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-30","filed_date":"2010-12-02","scope":"insider"},{"id":7186915,"accession":"0001458177-10-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001458177-10-000001","line_url":"/filing/0001458177-10-000001","is_derivative":false,"issuer_cik":"0001239242","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001239242","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings, LLC; Hove Anders D; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; ROBERTS BRYAN E","owner_display_name":"VHCP Co-Investment Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99000.0,"shares_display":"99,000","price_per_share":6.2995,"price_display":"6.30","price_state":"stated","total_value":623650.5,"total_display":"623,650.50","total_whole":"623,651","shares_owned_after":3024253.0,"shares_owned_after_display":"3,024,253","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-20","filed_date":"2010-09-22","scope":"insider","n_lines":2},{"id":7572209,"accession":"0001365618-10-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001365618-10-000004","line_url":"/filing/0001365618-10-000004#line-4","is_derivative":false,"issuer_cik":"0001267602","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001267602","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":306071.0,"shares_display":"306,071","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":3366781.0,"total_display":"3,366,781.00","total_whole":"3,366,781","shares_owned_after":3949070.0,"shares_owned_after_display":"3,949,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-27","filed_date":"2010-04-28","scope":"insider"},{"id":7204705,"accession":"0001365618-10-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001365618-10-000002","line_url":"/filing/0001365618-10-000002#line-1","is_derivative":false,"issuer_cik":"0001024520","issuer_name":"WORLD HEART CORP","issuer_ticker":"WHRT","issuer_name_source":null,"issuer_url":"/issuer/0001024520","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":388350.0,"shares_display":"388,350","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":2000002.5,"total_display":"2,000,002.50","total_whole":"2,000,003","shares_owned_after":4055016.0,"shares_owned_after_display":"4,055,016","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-21","filed_date":"2010-01-26","scope":"insider"},{"id":3670115,"accession":"0001365618-06-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001365618-06-000002","line_url":"/filing/0001365618-06-000002","is_derivative":false,"issuer_cik":"0001298521","issuer_name":"Trubion Pharmaceuticals, Inc","issuer_ticker":"TRBN","issuer_name_source":null,"issuer_url":"/issuer/0001298521","owner_cik":"0001365618","owner_name":"Hove Anders D","owner_display_name":"Hove Anders D","owner_url":"/insider/0001365618","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35181.0,"shares_display":"35,181","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":457353.0,"total_display":"457,353.00","total_whole":"457,353","shares_owned_after":1512111.0,"shares_owned_after_display":"1,512,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-23","filed_date":"2006-10-25","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"OnKure Therapeutics, Inc.","url":"/issuer/0001637715","role":"Ten percent owner","n_filings":1,"first_seen":"2025-05-19","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001609550","name":"Inspire Medical Systems, Inc.","url":"/issuer/0001609550","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-09","last_seen":"2018-05-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2010-12-02","last_seen":"2016-05-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001472091","name":"Edge Therapeutics, Inc.","url":"/issuer/0001472091","role":"Director","n_filings":1,"first_seen":"2015-10-08","last_seen":"2015-10-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Avalanche Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Ten percent owner","n_filings":1,"first_seen":"2014-08-07","last_seen":"2014-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001333763","name":"Chelsea Therapeutics International, Ltd.","url":"/issuer/0001333763","role":"Ten percent owner","n_filings":2,"first_seen":"2010-09-22","last_seen":"2011-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2010-04-28","last_seen":"2010-04-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001024520","name":"WORLD HEART CORP","url":"/issuer/0001024520","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2010-01-26","last_seen":"2010-01-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001298521","name":"Trubion Pharmaceuticals, Inc","url":"/issuer/0001298521","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2006-10-25","last_seen":"2006-10-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001365618","retrieved_at":"2026-08-27T08:44:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}